In her first speech to FDA staff, Tracey Høeg, the new top drug regulator, announced plans to review the safety of SSRI drugs used in pregnancy. He also wants to question the safety of RSV injections given to infants. Høeg will focus on data on these interventions during pregnancy and in newborns. The speech was her first public appearance in office. With this move, the FDA signals increased scrutiny of existing recommendations.